The global hematopoietic stem cell transplantation market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The Major driver in the hematopoietic stem cell transplantation market is the growing network of hematopoietic stem cell transplantation organizations that have reached across the globe and have been seen by an NGO called the Worldwide Network for Blood and Marrow Transplantation Group officially affiliated with the World Health Organization. The growing network has boosted the market owing to the joint ventures which have developed the technology to show the good result to the people which leads them to grow faith in the transplant for health issues. For instance, in July 2019, Omeros Corporation and Lonza announced a long-term manufacturing agreement for the commercial production of narsoplimab, Omeros' lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), also referred to as OMS721. Omeros is preparing to submit a biologics license application (BLA) and a marketing authorization application (MAA) to the U.S. Food and Drug Administration (FDA) and to the European Medicines Agency (EMA), respectively, for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
Browse the full report description “Global Hematopoietic Stem Cell Transplantation Market Size, Share & Trends Analysis Report by Transplant Type (Allogenic, and Autologous), by Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Others) and by Application (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Others) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/hematopoietic-stem-cell-transplantation-market
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including Lonza Group, Merck & Co. Inc., Pluristem Therapeutics Inc., and others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected regions and segment
Global Hematopoietic Stem Cell Transplantation Market Report Segment
By Transplant Type
By Indication
By Application
Global Hematopoietic Stem Cell Transplantation Market Report Segment by Region
North America
• US
• Canada
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hematopoietic-stem-cell-transplantation-market